Literature DB >> 825907

Effects of cholinergic agonists and antagonists on morphine-withdrawal syndrome.

M D Hynes, G Gianutsos, H Lal.   

Abstract

The effects of pilocarpine, atropine and dexetimide were studied on the occurrence and intensity of morphine-withdrawal signs observed after cessation of chronic morphine injections. Pilocarpine was effective in reducing both 'wet-dog' like body shakes and aggression but it increased diarrhea and weight loss. Pretreatment with atropine blocked all of the effects of pilocarpine on withdrawal signs. Methylscopolamine pretreatment blocked only diarrhea. The administration of atropine or dexetimide produced no significant effect on any of the withdrawal signs. These results indicate a role for central cholinergic mechanism in narcotic withdrawal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825907     DOI: 10.1007/BF00427289

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.

Authors:  H Lal; G Gianutsos; S K Puri
Journal:  Life Sci       Date:  1975-07-01       Impact factor: 5.037

2.  Blockade of morphine-withdrawal body shakes by haloperidol.

Authors:  H Lal; R Numan
Journal:  Life Sci       Date:  1976-01-15       Impact factor: 5.037

3.  A comparison of haloperidol with methadone in blocking heroin-withdrawal symptoms. A pilot study.

Authors:  J Karkalas; H Lal
Journal:  Int Pharmacopsychiatry       Date:  1973

4.  Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.

Authors:  A Herz; J Bläsig; R Papeschi
Journal:  Psychopharmacologia       Date:  1974

5.  Letter: Enhanced utilization of brain acetylcholine during morphine withdrawal in the rat.

Authors:  E F Domino; A E Wilson
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

6.  Cholinergic modification of naloxone-induced jumping in morphine dependent mice.

Authors:  D A Brase; L F Tseng; H H Loh; E L Way
Journal:  Eur J Pharmacol       Date:  1974-04       Impact factor: 4.432

7.  Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice.

Authors:  H N Bhargava; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1972-10       Impact factor: 4.030

8.  Studies on the central antinociceptive action of cholinomimetic agents.

Authors:  J Metys; N Wagner; J Metysová; A Herz
Journal:  Int J Neuropharmacol       Date:  1969-09

9.  Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice.

Authors:  N W Pedigo; W L Dewey; L S Harris
Journal:  J Pharmacol Exp Ther       Date:  1975-06       Impact factor: 4.030

10.  Paradoxical absence of aggression during naloxone-precipitated morphine withdrawal.

Authors:  G Gianutsos; M D Hynes; R B Drawbaugh; H Lal
Journal:  Psychopharmacologia       Date:  1975-07-23
View more
  2 in total

1.  Acute HPA axis response to naltrexone differs in female vs. male smokers.

Authors:  Daniel J O Roche; Emma Childs; Alyssa M Epstein; Andrea C King
Journal:  Psychoneuroendocrinology       Date:  2009-10-17       Impact factor: 4.905

2.  An electromyographic method for the assessment of naloxone-induced abstinence in morphine-dependent rats.

Authors:  M K Menon; L F Tseng; H H Loh; W G Clark
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.